Characterization of the antagonist actions of 5-BDBD at the rat P2X4 receptor
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 690, 219-224
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Child Health and Human Development, NIH
- FONDECYT Initiation Grant (11121302, 1161490)
- CONICYT Ph.D. Fellowship (21181885)
This publication has 36 references indexed in Scilit:
- Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studiesBiochemical Pharmacology, 2017
- Identification and Characterization of a Selective Allosteric Antagonist of Human P2X4 Receptor ChannelsMolecular Pharmacology, 2015
- ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathyThe International Journal of Biochemistry & Cell Biology, 2013
- Investigation of the Inhibitory Effects of the Benzodiazepine Derivative, 5-BDBD on P2X4Purinergic Receptors by two Complementary MethodsCellular Physiology and Biochemistry, 2013
- Activation and Regulation of Purinergic P2X Receptor ChannelsPharmacological Reviews, 2011
- Allosteric modulation of ATP-gated P2X receptor channelsReviews in the Neurosciences, 2011
- Discovery of Potent Competitive Antagonists and Positive Modulators of the P2X2 ReceptorJournal of Medicinal Chemistry, 2011
- Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistBioorganic & Medicinal Chemistry Letters, 2010
- Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptorsBritish Journal of Pharmacology, 2009
- Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of painBioorganic & Medicinal Chemistry Letters, 2009